 |
|
Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study
Murat Beyazyüz, Yakup Albayrak, Oğuzhan Bekir Eğilmez, Neslihan Albayrak, Elmas Beyazyüz
Psychiatry Investig. 2013;10(2):148-154. Published online 2013 May 30 DOI: https://doi.org/10.4306/pi.2013.10.2.148
|
|
Effect of Vortioxetine in Comparison to Fluoxetine on Metabolic Parameters in Patients With Depressive Disorder: A Randomized Controlled Trial
Karthik Sankar, Abdul Ajeed Mohathasim Billah, Natrajan Shanmugasundram, Sankar Veintramuthu, Sushma Viswanathan
Cureus.2024;[Epub] CrossRef Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Yana Zorkina, Valeria Ushakova, Aleksandra Ochneva, Anna Tsurina, Olga Abramova, Valeria Savenkova, Anna Goncharova, Irina Alekseenko, Irina Morozova, Daria Riabinina, Georgy Kostyuk, Anna Morozova
Metabolites.2024; 14(2): 80. CrossRef Dysregulation of adipogenesis and disrupted lipid metabolism by the antidepressants citalopram and sertraline
Deniz Bozdag, Jeroen van Voorthuizen, Nikita Korpel, Sander Lentz, Hande Gurer-Orhan, Jorke H. Kamstra
Toxicology and Applied Pharmacology.2024; : 116937. CrossRef 3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort
O. Godin, B. Pignon, A. Szoke, L. Boyer, B. Aouizerate, B. Schorr, M. André, D. Capdevielle, I. Chereau, N. Coulon, R. Dassing, C. Dubertret, B. Etain, S. Leignier, P.M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, M. Urbach, F. Schürhoff, M. Le
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2023; 120: 110641. CrossRef Transcriptional changes in specific subsets of Drosophila neurons following inhibition of the serotonin transporter
Shivan L. Bonanno, David E. Krantz
Translational Psychiatry.2023;[Epub] CrossRef Metabolic syndrome in patients with obsessive-compulsive disorder
Mohammadrasoul Khalkhali, Kiarash Rasekh, Fatemeh Eslamdoust-Siahestalkhi, Hassan Farrahi, Roghaye Zare
Frontiers in Psychiatry.2023;[Epub] CrossRef OS03-04: Metabolic profiling of women using SSRI medication during pregnancy with targeted NMR metabolomics approach
A. Itkonen, O. Kärkkäinen, H. Sahlman, L. Keski-Nisula, J. Rysä
Toxicology Letters.2023; 384: S68. CrossRef Is There Any Risk for Metabolic Syndrome in Children and Adolescents with Psychiatric Disorders?
Öznur Bilaç, Akın Tahıllıoğlu, Burak Çakır, Canem Kavurma, Arif Önder, Eyüp Sabri Ercan
Dubai Medical Journal.2023; 6(4): 261. CrossRef A systematic review of randomized controlled trials assessing the effect of Vortioxetine on metabolic syndrome risk indicators in patients with depression
Karthik Sankar, Sushma Viswanathan, Uma maheswari mugundan, Roshini Kizhakkedeth Nazar, Saranya Ramasamy, Rajanandh Muhasaparur Ganesan
Health Sciences Review.2023; 9: 100129. CrossRef Effects of Combined Sertraline and Magnesium in Rat Atrium
Esra Fidan, Z. Isik Solak Gormus, İbrahim Kilinc, Mehmet Sinan İyisoy, Niyazi Gormus
Biological Trace Element Research.2022; 200(2): 652. CrossRef Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review
Zizhen Zhang, Yang Du, Lizhi Chen, Ying Liu, Biao Du
Asian Journal of Psychiatry.2022; 73: 103092. CrossRef Effects of a Gamified, Behavior Change Technique–Based Mobile App on Increasing Physical Activity and Reducing Anxiety in Adults With Autism Spectrum Disorder: Feasibility Randomized Controlled Trial
Daehyoung Lee, Georgia C Frey, Donetta J Cothran, Jaroslaw Harezlak, Patrick C Shih
JMIR Formative Research.2022; 6(7): e35701. CrossRef Antidepressant-like potential of silymarin and silymarin-sertraline combination in mice: Highlighting effects on behaviour, oxidative stress, and neuroinflammation
Adejoke Yetunde Onaolapo, Hameed Sulaiman, Anthony Tope Olofinnade, Olakunle James Onaolapo
World Journal of Pharmacology.2022; 11(3): 27. CrossRef Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study
Katrine K. Fjukstad, Lavinia Athanasiu, Shahram Bahrami, Kevin S. O’Connell, Dennis van der Meer, Francesco Bettella, Ingrid Dieset, Nils Eiel Steen, Srdjan Djurovic, Olav Spigset, Ole A. Andreassen
The Pharmacogenomics Journal.2021; 21(5): 574. CrossRef Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach
Alfredo Bellon, Kieuhanh Nguyen
World Journal of Psychiatry.2021; 11(7): 316. CrossRef Antidepressant Drugs Effects on Blood Pressure
Anna Calvi, Ilaria Fischetti, Ignazio Verzicco, Martino Belvederi Murri, Stamatula Zanetidou, Riccardo Volpi, Pietro Coghi, Stefano Tedeschi, Mario Amore, Aderville Cabassi
Frontiers in Cardiovascular Medicine.2021;[Epub] CrossRef Treatment dilemma of a depressed patient with metabolic syndrome
Khalid Al Jalahma, Najib Al Qsous
Endocrinology&Metabolism International Journal.2021; 9(3): 50. CrossRef Effects of mindfulness-based stress reduction on anxiety symptoms in young people: A systematic review and meta-analysis
Xiang Zhou, Jieyu Guo, Guangli Lu, Chaoran Chen, Zhenxing Xie, Jiangmin Liu, Chuning Zhang
Psychiatry Research.2020; 289: 113002. CrossRef Comparison of the effects of sertraline and agomelatine on sleep quality, sexual functioning and metabolic parameters in patients with major depressive disorder
Anıl Talas, Cem Cerit, Esma Akpınar Aslan
Psychiatry and Clinical Psychopharmacology.2019; 29(3): 257. CrossRef Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function
Sofia Cussotto, Conall R. Strain, Fiona Fouhy, Ronan G. Strain, Veronica L. Peterson, Gerard Clarke, Catherine Stanton, Timothy G. Dinan, John F. Cryan
Psychopharmacology.2019; 236(5): 1671. CrossRef Impact of sertraline on weight, waist circumference and glycemic control: A prospective clinical trial on depressive diabetic type 2 patients
Chaima Rachdi, Rahma Damak, Feten Fekih Romdhane, Haroun Ouertani, Majda Cheour
Primary Care Diabetes.2019; 13(1): 57. CrossRef Fluoxetine for adults who are overweight or obese
Aurora E Serralde-Zúñiga, Alejandro G Gonzalez Garay, Yanelli Rodríguez-Carmona, Guillermo Melendez
Cochrane Database of Systematic Reviews.2019;[Epub] CrossRef Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut
Thomas C. Fung, Helen E. Vuong, Cristopher D. G. Luna, Geoffrey N. Pronovost, Antoniya A. Aleksandrova, Noah G. Riley, Anastasia Vavilina, Julianne McGinn, Tomiko Rendon, Lucy R. Forrest, Elaine Y. Hsiao
Nature Microbiology.2019; 4(12): 2064. CrossRef Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics
K.K. Fjukstad, A. Engum, S. Lydersen, I. Dieset, N. Eiel Steen, O.A. Andreassen, O. Spigset
European Psychiatry.2018; 48(1): 71. CrossRef Effect of fluoxetine on three-year recurrence in acute ischemic stroke: A randomized controlled clinical study
Yitao He, Zhili Cai, Siling Zeng, Siyan Chen, Bingshan Tang, Yubing Liang, Xin Chang, Yi Guo
Clinical Neurology and Neurosurgery.2018; 168: 1. CrossRef The Impact of Prolonged, Selective, Serotonin Reuptake Inhibitor Treatment on Serum Lipid and Glucose Levels in Children and Adolescents: A Preliminary Prospective Study
Lior Schapir, Abraham Weizman, Pavel Golubchik
Journal of Child and Adolescent Psychopharmacology.2018; 28(7): 485. CrossRef Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review
Diego Bulcão Visco, Raul Manhães-de-Castro, Wenicios Ferreira Chaves, Diego Cabral Lacerda, Sabrina da Conceição Pereira, Kelli Nogueira Ferraz-Pereira, Ana Elisa Toscano
Pharmacological Research.2018; 136: 194. CrossRef Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review
Carla Gramaglia, Eleonora Gambaro, Giuseppe Bartolomei, Paolo Camera, Maira Chiarelli-Serra, Luca Lorenzini, Patrizia Zeppegno
Frontiers in Psychiatry.2018;[Epub] CrossRef The Antidepressants and the Metabolic Syndrome
Kolcsár Melinda, Gáll Zsolt, Bába László-István, Kun Imre Zoltán
Bulletin of Medical Sciences.2018; 91(2): 89. CrossRef The impact of treatment with selective serotonin reuptake inhibitors on primate cardiovascular disease, behavior, and neuroanatomy
Carol A. Shively, Marnie Silverstein-Metzler, Jamie Justice, Stephanie L. Willard
Neuroscience & Biobehavioral Reviews.2017; 74: 433. CrossRef Duloxetine in treating generalized anxiety disorder in adults: A meta‐analysis of published randomized, double‐blind, placebo‐controlled trials
Yingli Zhang, Guoping Huang, Shichang Yang, Wei Liang, Lei Zhang, Changhong Wang
Asia-Pacific Psychiatry.2016; 8(3): 215. CrossRef BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE
Sarah A. Hiles, Dóra Révész, Femke Lamers, Erik Giltay, Brenda W. J. H. Penninx
Depression and Anxiety.2016; 33(8): 754. CrossRef Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys
Marnie G. Silverstein-Metzler, Carol A. Shively, Thomas B. Clarkson, Susan E. Appt, J.Jeffrey Carr, Stephen B. Kritchevsky, Sara R. Jones, Thomas C. Register
Psychoneuroendocrinology.2016; 68: 29. CrossRef Effects of depression pharmacotherapy in fertility treatment on conception, birth, and neonatal health: A systematic review
Leo E. Akioyamen, Hersimren Minhas, Alison C. Holloway, Valerie H. Taylor, Noel O. Akioyamen, Diana Sherifali
Journal of Psychosomatic Research.2016; 84: 69. CrossRef Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder
Katrine Kveli Fjukstad, Anne Engum, Stian Lydersen, Ingrid Dieset, Nils Eiel Steen, Ole A. Andreassen, Olav Spigset
Journal of Clinical Psychopharmacology.2016; 36(6): 615. CrossRef Effects of Fluoxetine on Neural Functional Prognosis after Ischemic Stroke: A Randomized Controlled Study in China
Yi-Tao He, Bing-Shan Tang, Zhi-Li Cai, Si-Ling Zeng, Xin Jiang, Yi Guo
Journal of Stroke and Cerebrovascular Diseases.2016; 25(4): 761. CrossRef Long term sertraline effects on neural structures in depressed and nondepressed adult female nonhuman primates
Stephanie L. Willard, Beth Uberseder, Ashlee Clark, James B. Daunais, Warwick D. Johnston, David Neely, Adreanna Massey, Jeff D. Williamson, Robert A. Kraft, J. Daniel Bourland, Sara R. Jones, Carol A. Shively
Neuropharmacology.2015; 99: 369. CrossRef Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats
Nicole E. De Long, Eric J. Barry, Christopher Pinelli, Geoffrey A. Wood, Daniel B. Hardy, Katherine M. Morrison, Valerie H. Taylor, Hertzel C. Gerstein, Alison C. Holloway
Toxicology and Applied Pharmacology.2015; 285(1): 32. CrossRef Effects of Long-Term Sertraline Treatment and Depression on Coronary Artery Atherosclerosis in Premenopausal Female Primates
Carol A. Shively, Thomas C. Register, Susan E. Appt, Thomas B. Clarkson
Psychosomatic Medicine.2015; 77(3): 267. CrossRef Significant Reduction of Aggression with Guanfacine Extended Release in an Adolescent with Prader–Willi Syndrome
Deepan Singh, Nevil Kadakia, Aaron Pinkhasov
Journal of Child and Adolescent Psychopharmacology.2015; 25(4): 376. CrossRef Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: Findings from the 2012 Canadian Community Health Survey — Mental Health (CCHS-MH)
Sonya S. Deschênes, Rachel J. Burns, Norbert Schmitz
Journal of Psychosomatic Research.2015; 78(2): 137. CrossRef Fluoxetine-induced pancreatic beta cell dysfunction: New insight into the benefits of folic acid in the treatment of depression
Nicole E De Long, Jillian R Hyslop, Sandeep Raha, Daniel B Hardy, Alison C Holloway
Journal of Affective Disorders.2014; 166: 6. CrossRef
|